Skip to content

Lung Cancer – Linnea Olson Patient Story_1

Related Blog Posts

Making AI work where it matters, with Rob DiCicco

https://www.transceleratebiopharmainc.com/wp-content/uploads/2020/10/Lung-Cancer-Linnea-Olson-Patient-Story_1.mp4 In a new pharmaphorum podcast, web editor Nicole Raleigh was joined by Rob DiCicco, vice president of portfolio management at Transcelerate Biopharma Inc, for a conversation on the barriers and the breakthroughs in making AI work in drug development and clinical trials. Read the full article featuring Rob DiCicco from Pharmaphorum here.

From Vision to Value: A Blueprint for Implementing Industry Consortia Innovations

https://www.transceleratebiopharmainc.com/wp-content/uploads/2020/10/Lung-Cancer-Linnea-Olson-Patient-Story_1.mp4 Our healthcare landscape is rapidly evolving and presenting us with complex challenges: modernizing clinical trials, ethically integrating artificial intelligence, and delivering patient-centric care. No single organization can tackle these issues alone.  Read the full article from DIA Global Forum here.

TransCelerate Highlights Digital Momentum and Global Collaboration in 2025 Annual Report

https://www.transceleratebiopharmainc.com/wp-content/uploads/2020/10/Lung-Cancer-Linnea-Olson-Patient-Story_1.mp4 TransCelerate BioPharma has released its 2025 annual report, titled The Power of Forward, outlining a year defined by continued digital adoption, regulatory collaboration, and expansion of pragmatic approaches to clinical development. Read the full article featuring Janice Chang from Applied Clinical Trials here.